ClassID:

170511

G01N2333/72 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants for hormones

Sub-classes:
Recent Application in this class:
#1
20250341519
2025-11-06

SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID

#2
20250127814
2025-04-24

BOREALIN TARGETING POLYPEPTIDES FOR DETECTION AND TREATMENT OF CANCER

#3
20240230646
2024-07-11

HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION

#4
20240133885
2024-04-25

HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION

#5
20230266340
2023-08-24

Measurement, Diagnosis, Treatment and Management of Metabolic Syndrome

#6
20230266316
2023-08-24

Somatostatin Receptor

#7
20230234994
2023-07-27

VASOPRESSIN-2 RECEPTOR ANTAGONIST PEPTIDES AND USES THEREOF

#8
20230058794
2023-02-23

SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID

#9
20220381795
2022-12-01

Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity

#10
20220341941
2022-10-27

PROTEINS TARGETING ORTHOLOGS

#11
20210285974
2021-09-16

RAPID POLYMERIZATION OF POLYPHENOLS

#12
20210140946
2021-05-13

SYNCYTIOTROPHOBLAST EXTRACELLULAR VESICLES AS BIOMARKER FOR GESTATIONAL DIABETES MELLITUS

#13
20200400682
2020-12-24

Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity

#14
20200225250
2020-07-16

hGH Determination for Use to Guide Prevention of a Major Adverse Cardiac Event or a Cardiovascular Disease in a Subject

#15
20200080977
2020-03-12

Chemical sensor and method for detecting target substance

#16
20190331696
2019-10-31

Compositions and methods for enhancing neuro-repair

#17
20190317105
2019-10-17

Method of Identifying Transmembrane Protein-interacting Compounds

#18
20190285647
2019-09-19

SRM/MRM Assays For CD56 And CHGA Proteins

#19
20190107537
2019-04-11

Highly sensitive and specific luciferase based reporter assay for antigen detection

#20
20190076553
2019-03-14

METHODS AND ASSAYS FOR TREATING SUBJECTS WITH SHANK3 DELETION, MUTATION OR REDUCED EXPRESSION

#21
20190056391
2019-02-21

System for detecting infection in synovial fluid

#22
20180311304
2018-11-01

Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N

#23
20180306814
2018-10-25

Method for detecting neutralizing antibodies against recombinant human insulin in human serum

#24
20180267051
2018-09-20

Method of Identifying Transmembrane Protein-interacting Compounds

#25
20180259536
2018-09-13

Proteins targeting orthologs

#26
20170336418
2017-11-23

Method of Identifying Transmembrane Protein-interacting Compounds

#27
20170234889
2017-08-17

hGH Determination for Use to Guide Prevention of a Major Adverse Cardiac Event or a Cardiovascular Disease in a Subject

#28
20170168070
2017-06-15

Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity

#29
20170166625
2017-06-15

Soluble monomeric anti-Mullerian hormone receptor type II fusion proteins and uses thereof

#30
20170035903
2017-02-09

Antibodies, antibody drug conjugates and methods of use

#31
20170022277
2017-01-26

Insulin-like growth factor 1 receptor-specific antibodies and uses thereof

#32
20170015749
2017-01-19

Insulin-like growth factor 1 receptor-specific antibodies and uses thereof

#33
20170015748
2017-01-19

Insulin-like growth factor 1 receptor-specific antibodies and uses thereof

#34
20160349265
2016-12-01

Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay

#35
20160274132
2016-09-22

Marker of cell death

#36
20160168246
2016-06-16

Method for treating tumors that possess the CCK-C receptor with the 3B9.1 monoclonal antibody

#37
20160131665
2016-05-12

SRM/MRM assay for the insulin receptor protein

#38
20160084851
2016-03-24

NOVEL BIOMARKERS

#39
20150377909
2015-12-31

Biomarkers and methods for measuring and monitoring inflammatory disease activity

#40
20150232563
2015-08-20

Mutated humanized 12G4 antibodies and the fragments thereof against the human anti-Mullerian hormone receptor type II

#41
20150197520
2015-07-16

Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators

#42
20150133383
2015-05-14

METHOD FOR DIAGNOSIS AND TREATMENT OF PROLACTIN ASSOCIATED DISORDERS

#43
20140322245
2014-10-30

SRM/MRM assay for the insulin receptor protein

#44
20140057894
2014-02-27

Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators

#45
20130084581
2013-04-04

Method of identifying transmembrane protein-interacting compounds

#46
20120295990
2012-11-22

Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay

#47
20120270923
2012-10-25

Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer

#48
20120216302
2012-08-23

Methods and assays for treating subjects with SHANK3 deletion, mutation or reduced expression

#49
20120009607
2012-01-12

DIFFERENTIATING CARDIAC- AND DIABETES MELLITUS-BASED CAUSES OF KIDNEY DAMAGE

#50
20110275644
2011-11-10

BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE INHIBITORS

#51
20110203008
2011-08-18

Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on the oestrogen receptor and its intracellular receptors, and method for the preparation thereof

#52
20110150760
2011-06-23

PRLR-specific antibody and uses thereof

#53
20110137851
2011-06-09

Biomarkers and methods for measuring and monitoring inflammatory disease activity

#54
20110052668
2011-03-03

Identification and characterization of a specific CCK-C receptor antibody for human pancreatic cancer and its use for early detection and staging of pancreatic cancer

#55
20110028335
2011-02-03

Ligands for the GLP-1 receptor and methods for discovery thereof

#56
20110014626
2011-01-20

METHODS FOR MEASURING THE INSULIN RECEPTOR ALPHA SUBUNIT

#57
20110003317
2011-01-06

METHODS OF SCREENING COMPOUNDS FOR INSECT-CONTROL ACTIVITY INVOLVING THE TYRAMINE RECEPTOR

#58
20100298234
2010-11-25

Cancer therapeutic agents comprising a ligand for the neuromedin u receptor 2 (fm4) molecule as an active ingredient

#59
20100279318
2010-11-04

Method of identifying transmembrane protein-interacting compounds

#60
20100216162
2010-08-26

Immunological Method, Test Kit and Device for the Determination of the Analyte Content of a Sample

#61
20100215577
2010-08-26

Compositions and methods for visualizing and eliminating cancer stem cells

#62
20100183578
2010-07-22

Method for identifying smoker or ex-smoker at risk of chronic obstructive pulmonary disease

#63
20100098688
2010-04-22

Method for diagnosis of systemic sclerosis involving an anti-AT1-receptor antibody

#64
20100093005
2010-04-15

IDENTIFYING DUCT CANCERS

#65
20100092523
2010-04-15

Molecules and methods for treatment and detection of cancer

#66
20100069463
2010-03-18

Method of treating depression

#67
20090311702
2009-12-17

TESTS TO PREDICT RESPONSIVENESS OF CANCER PATIENTS TO CHEMOTHERAPY TREATMENT OPTIONS

#68
20090304714
2009-12-10

IKKi Inhibitor Therapies and Screening Methods, and Related IKKi Diagnostics

#69
20090089888
2009-04-02

Sour/Acid Taste Receptors Assays, Genes and Proteins

#70
20090081691
2009-03-26

Method of identifying transmembrane protein-interacting compounds

#71
20090061467
2009-03-05

Methods and Compositions for Measuring Canine BNP and Uses Thereof

#72
20090025095
2009-01-22

Method for Evaluating Compound Using Barlp and Substance for Regulating Eating and Body Weight

#73
20080305098
2008-12-11

Recombinant Polypeptides and Methods for Detecting and/or Quantifying Autoantibodies Against Tsh Receptor

#74
20080292620
2008-11-27

PRLR-specific antibody and uses thereof

#75
20080263689
2008-10-23

Methods for identifying modulators of protein kinase C-epsilon (PKC) and method of treatment of aberrant glucose metabolism associated therewith

#76
20080118918
2008-05-22

Compositions and Methods For Determining and Predicting Treatment Responses For Depression and Anxiety

#77
20080038247
2008-02-14

Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39)

#78
20070243192
2007-10-18

Growth hormone receptor antagonist cancer treatment

#79
20070238649
2007-10-11

Agents for Regulating Adiponectin Receptor Expression

#80
20070196857
2007-08-23

Methods for decreasing risk of complications of prematurity using IGF-I and its analogs

#81
20070117969
2007-05-24

PTH receptor and screening assay utilizing the same

#82
20070105104
2007-05-10

Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4)

#83
20070098636
2007-05-03

Method of identifying responders to treatment with insulin sensitizers

#84
20070065891
2007-03-22

Mehod of pretreating sample and immunological assay method using the same

#85
20070065884
2007-03-22

Mammalian sour/acid taste and CSF receptor genes, polypeptides and assays

#86
20070059784
2007-03-15

Methods for measuring the insulin receptor α subunit

#87
20070059694
2007-03-15

Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep1 (prostaglandin e2 ep1)

#88
20070042409
2007-02-22

Mammalian obestatin receptors

#89
20070015220
2007-01-18

Guanosine triphosphate (GTP) binding protein-coupled receptor proteins that bind histamine and are expressed in the brain

#90
20070003928
2007-01-04

Novel use of edg receptors

#91
20070003532
2007-01-04

Mechanism for identifying drugs for the treatment of type II diabetes

#92
20060263403
2006-11-23

Compositions and methods for controlling insects involving the tyramine receptor

#93
20060216757
2006-09-28

Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof

#94
20060188945
2006-08-24

Screening methods

#95
20060127928
2006-06-15

Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor

#96
20060088829
2006-04-27

Minrs as modifiers of insulin receptor signaling and methods of use

#97
20060057649
2006-03-16

Screening method and anti-tumor drug candidate obtained therefrom

#98
20060051825
2006-03-09

Methods and compositions for measuring canine BNP and uses thereof

#99
20050287602
2005-12-29

Method of identifying transmembrane protein-interacting compounds

#100
20050204416
2005-09-15

Plant cells having receptor polypeptides

#101
20050169839
2005-08-04

Biomarker for efficacy of appetite suppressant drugs

#102
20050048522
2005-03-03

Guanosine triphosphate (GTP) binding protein-coupled receptor proteins

#103
20050037404
2005-02-17

Methods of modulating drug clearance mechanisms by altering SXR activity

#104
20050020519
2005-01-27

Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity